Patents by Inventor Tyler Witte
Tyler Witte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12656310Abstract: A diagnostic system that includes a cartridge and a reader is discussed herein. The cartridge can contain a patient sample, such as a blood sample. The cartridge is inserted into the reader and the patient sample is analyzed. The reader contains various analysis systems, such as an electrophoresis detection system that uses electrophoresis testing to identify and quantify various components of the blood sample. The reader can process data from the various patient sample analysis to provide interpretative results indicative of a disorder, condition, disease, or infection of the patient.Type: GrantFiled: August 28, 2023Date of Patent: June 16, 2026Assignee: Hemex Health, Inc.Inventors: Peter Galen, Umut Atakan Gurkan, Muhammad Noman Hasan, James Daren Bledsoe, Tyler Witte
-
Publication number: 20250341472Abstract: The disclosed methods and systems use multiple images of a sample test strip used in a lateral flow assay to enhance detection and improve quantification of analyte(s) present in a patient sample. The multiple images are combined into a single image, which is then collapsed into a signal representative of a single 2D image with reduced noise.Type: ApplicationFiled: April 28, 2023Publication date: November 6, 2025Inventors: Peter Galen, James Daren Bledsoe, Alireza Avanaki, Benjamin Holt Bishop, Tyler Witte, Yiyang Fei, John Hinshaw, Matthew Christian Lind
-
Publication number: 20240241080Abstract: Electrophoresis is used to identify presence of a target compound in a patient sample based on a charge state of the compound. The charge state of the compound correlates to a total net charge of a binder conjugated to the compound. The bound complex is then applied to the electrophoresis substrate. An electric potential is applied to the substrate for a time period and causes the bound complex to migrate toward the electrode with opposite charge of the bound complex at a migration velocity to form a migration pattern over the time period. At some time during or at the end of the time period, the bound complex produces a bound complex band as a result of its migration across the substrate. The presence of the compound is identified based on the bound complex band and one or both of the migration pattern and the migration velocity.Type: ApplicationFiled: March 27, 2024Publication date: July 18, 2024Inventors: Peter GALEN, Ariane Elizabeth ERICKSON, David Richard BELL, Matthew Christian LIND, Tyler WITTE, Umut Atakan GURKAN
-
Publication number: 20240201132Abstract: The disclosed methods and systems use multi-spectral imaging of band data in point-of-care devices during active electrophoresis test runs to detect sensitive disease state compounds, such as hemoglobin and its variants and sub-variants. The multi-spectral imaging identifies an imaging wavelength of light that, when emitted towards the electrophoresis strip, optimizes images of the electrophoresis strip that are captured during the test. These optimized images allow for detection of the target compound, particularly at low concentrations and with low limits of detection (LoD).Type: ApplicationFiled: April 25, 2022Publication date: June 20, 2024Inventors: Peter GALEN, David John SAYLER, James Daren BLEDSOE, Muhammad Noman HASAN, Joshua King HOYT, Jered WIKANDER, Tyler WITTE, Alireza AVANAKI, Yiyang FEI, Anne ROCHELEAU, Umut Atakan GURKAN
-
Patent number: 11971384Abstract: Electrophoresis is used to identify presence of a target compound in a patient sample based on a charge state of the compound and a label. The charge state of the compound correlates to a total net charge of a binder conjugated to the compound. The bound complex or “bound complex” with the label is then applied to the electrophoresis substrate. An electric potential is applied to the substrate for a time period and causes the labeled bound complex to migrate toward the electrode with opposite charge of the labeled bound complex at a migration velocity to form a migration pattern over the time period. At some time during or at the end of the time period, the labeled bound complex produces a bound complex band as a result of its migration across the substrate. The presence of the compound is identified based on the labeled bound complex band and one or both of the migration pattern and the migration velocity.Type: GrantFiled: October 18, 2021Date of Patent: April 30, 2024Assignee: Hemex Health, Inc.Inventors: Peter Galen, Ariane Elizabeth Erickson, David Richard Bell, Matthew Christian Lind, Tyler Witte, Umut Atakan Gurkan
-
Publication number: 20230400431Abstract: A diagnostic system that includes a cartridge and a reader is discussed herein. The cartridge can contain a patient sample, such as a blood sample. The cartridge is inserted into the reader and the patient sample is analyzed. The reader contains various analysis systems, such as an electrophoresis detection system that uses electrophoresis testing to identify and quantify various components of the blood sample. The reader can process data from the various patient sample analysis to provide interpretative results indicative of a disorder, condition, disease, or infection of the patient.Type: ApplicationFiled: August 28, 2023Publication date: December 14, 2023Inventors: Peter Galen, Umut Atakan Gurkan, Muhammad Noman Hasan, James Daren Bledsoe, Tyler Witte
-
Patent number: 11740203Abstract: A diagnostic system that includes a cartridge and a reader is discussed herein. The cartridge can contain a patient sample, such as a blood sample. The cartridge is inserted into the reader and the patient sample is analyzed. The reader contains various analysis systems, such as an electrophoresis detection system that uses electrophoresis testing to identify and quantify various components of the blood sample. The reader can process data from the various patient sample analysis to provide interpretative results indicative of a disorder, condition, disease, or infection of the patient.Type: GrantFiled: June 25, 2020Date of Patent: August 29, 2023Assignee: Hemex Health, Inc.Inventors: Peter Galen, Umut Atakan Gurkan, Muhammad Noman Hasan, James Daren Bledsoe, Tyler Witte
-
Patent number: 11255815Abstract: Electrophoresis is used to identify presence of a target compound in a patient sample based on a charge state of the compound and a label. The charge state of the compound correlates to a total net charge of a binder conjugated to the compound. The bound complex or “bound complex” with the label is then applied to the electrophoresis substrate. An electric potential is applied to the substrate for a time period and causes the labeled bound complex to migrate toward the electrode with opposite charge of the labeled bound complex at a migration velocity to form a migration pattern over the time period. At some time during or at the end of the time period, the labeled bound complex produces a bound complex band as a result of its migration across the substrate. The presence of the compound is identified based on the labeled bound complex band and one or both of the migration pattern and the migration velocity.Type: GrantFiled: April 15, 2021Date of Patent: February 22, 2022Assignee: Hemex Health, Inc.Inventors: Peter Galen, Ariane Elizabeth Erickson, David Richard Bell, Matthew Christian Lind, Tyler Witte, Umut Atakan Gurkan
-
Publication number: 20220042946Abstract: Electrophoresis is used to identify presence of a target compound in a patient sample based on a charge state of the compound and a label. The charge state of the compound correlates to a total net charge of a binder conjugated to the compound. The bound complex or “bound complex” with the label is then applied to the electrophoresis substrate. An electric potential is applied to the substrate for a time period and causes the labeled bound complex to migrate toward the electrode with opposite charge of the labeled bound complex at a migration velocity to form a migration pattern over the time period. At some time during or at the end of the time period, the labeled bound complex produces a bound complex band as a result of its migration across the substrate. The presence of the compound is identified based on the labeled bound complex band and one or both of the migration pattern and the migration velocity.Type: ApplicationFiled: October 18, 2021Publication date: February 10, 2022Inventors: Peter GALEN, Ariane Elizabeth ERICKSON, David Richard BELL, Matthew Christian LIND, Tyler WITTE, Umut Atakan GURKAN
-
Publication number: 20210341360Abstract: A point-of-care diagnostic system that includes a cartridge and a reader. The cartridge can contain a patient sample, such as a blood sample. The cartridge is inserted into the reader and the patient sample is analyzed. The sample can be processed for data collection and analysis to provide interpretative results indicative of a disorder, condition, disease and/or infection of the patient. Processing can include external sonication and conjugating non-magnetic target material with magnetic nanoparticles and non-magnetic solids.Type: ApplicationFiled: October 17, 2019Publication date: November 4, 2021Inventors: Peter GALEN, Oren BERNSTEIN, James Daren BLEDSOE, Daniel E. GRUPP, Joshua King HOYT, David John SAYLER, James THORNE, Jered WIKANDER, Tyler WITTE
-
Publication number: 20210325341Abstract: Electrophoresis is used to identify presence of a target compound in a patient sample based on a charge state of the compound and a label. The charge state of the compound correlates to a total net charge of a binder conjugated to the compound. The bound complex or “bound complex” with the label is then applied to the electrophoresis substrate. An electric potential is applied to the substrate for a time period and causes the labeled bound complex to migrate toward the electrode with opposite charge of the labeled bound complex at a migration velocity to form a migration pattern over the time period. At some time during or at the end of the time period, the labeled bound complex produces a bound complex band as a result of its migration across the substrate. The presence of the compound is identified based on the labeled bound complex band and one or both of the migration pattern and the migration velocity.Type: ApplicationFiled: April 15, 2021Publication date: October 21, 2021Inventors: Peter GALEN, Ariane Elizabeth ERICKSON, David Richard BELL, Matthew Christian LIND, Tyler WITTE, Umut Atakan GURKAN
-
Publication number: 20200408715Abstract: A diagnostic system that includes a cartridge and a reader is discussed herein. The cartridge can contain a patient sample, such as a blood sample. The cartridge is inserted into the reader and the patient sample is analyzed. The reader contains various analysis systems, such as an electrophoresis detection system that uses electrophoresis testing to identify and quantify various components of the blood sample. The reader can process data from the various patient sample analysis to provide interpretative results indicative of a disorder, condition, disease, or infection of the patient.Type: ApplicationFiled: June 25, 2020Publication date: December 31, 2020Inventors: Peter Galen, Umut Atakan Gurkan, Muhammad Noman Hasan, James Daren Bledsoe, Tyler Witte